Post by Autolomous

The cell and gene therapy industry must break the mold to thrive, and BIO International Convention is where that conversation happened 🧬 Our CEO, Alexander Seyf, was among the leaders shaping the discussion. His message is clear: "Whatever direction you look into… it all is about data." From regulatory approval to payer reimbursement, Alexander challenged the sector to democratise information "without really infringing their IP", because shared data is what moves this industry forward. Other key themes from the floor: 💰 Economics: Commercial viability remains the defining hurdle. Speed to approval, pricing, and cost of manufacturing must all align for CGT to succeed. 🏭 Manufacturing: Paper-based processes are holding the industry back. Digitisation is no longer optional. 🤝 Collaboration: The COVID-19 response showed what's possible when biopharma, regulators, and government act with shared urgency. CGT needs that same energy Read the full article here: https://lnkd.in/dGJ-h9tg #CellAndGeneTherapy #BIO2026